5/24/2013

Canadian researchers found atorvastatin was associated with a 22% increased risk of new-onset diabetes, while patients who took rosuvastatin or simvastatin had an 18% and 10% increased risk of the condition, respectively, compared with patients taking pravastatin. Pravastatin, fluvastatin and lovastatin were tied to a slightly lower diabetes risk, researchers reported in BMJ.

Full Story:
HealthDay News

Related Summaries